Concepedia

Juliette Janson

JJ

Statistics

Publications

20

Citations

7.4K

H-Index

18

Active since

1996

Affiliations

AstraZeneca (Sweden)(Current)

Karolinska Institutet

University of Southern California

Science for Life Laboratory

Pfizer (United States)

Juliette Janson is an author at AstraZeneca (Sweden) specializing in life sciences, neurodegeneration, and neurodegenerative diseases.

Publications per year

1996–2019

20

Publications

20

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Alexandra E. Butler, Juliette Janson, Susan Bonner‐Weir et al. · Diabetes · 2003 · 4K citations

, , +17

Increased Risk of Type 2 Diabetes in Alzheimer Disease

Juliette Janson, Thomas Laedtke, Joseph E. Parisi et al. · Diabetes · 2004 · 956 citations · Full text

, , +17

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

Juliette Janson, Richard H. Ashley, David J. Harrison et al. · Diabetes · 1999 · 615 citations

, , +17

Increased β-Cell Apoptosis Prevents Adaptive Increase in β-Cell Mass in Mouse Model of Type 2 Diabetes

Alexandra E. Butler, Juliette Janson, Walter C. Soeller et al. · Diabetes · 2003 · 411 citations · Full text

, , +17

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.

Juliette Janson, Walter C. Soeller, Patrick C. Roche et al. · Proceedings of the National Academy of Sciences · 1996 · 340 citations · Full text

, , +16

1–5 of 20